Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. 2020

Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
School of Pharmacy, Nantong University, Nantong, China.

Chemodynamic therapy (CDT) takes the advantages of Fenton-type reactions triggered by endogenous chemical energy to generate highly cytotoxic hydroxyl radicals. As a novel modality for cancer treatment, CDT shows minimal invasiveness and high tumor specificity by responding to the acidic and the highly concentrated hydrogen peroxide microenvironment of tumor. The CDT approach for spatiotemporal controllable reactive oxygen species generation exhibits preferable therapeutic performance and satisfying biosafety. In this review article, we summarized the recent advances of stimuli-activatable nanomedicines for CDT. We also overviewed the strategies for augmenting CDT performance, including increasing the catalytic efficacy through rational design of the nanomaterials, modulating the reaction condition, inputting external energy field, and regulating the tumor microenvironment. Furthermore, we discussed the potential and challenges of stimuli-activatable nanomedicine for clinical translation and future development of CDT. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Diagnostic Tools > In Vivo Nanodiagnostics and Imaging.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017665 Hydroxyl Radical The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
March 2022, Asian journal of pharmaceutical sciences,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
August 2022, ACS omega,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
May 2022, Biomaterials science,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
February 2024, Nanotechnology,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
May 2023, Science bulletin,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
May 2021, Biomedical materials (Bristol, England),
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
November 2022, ACS nano,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
March 2023, Acta biomaterialia,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
August 2023, Journal of functional biomaterials,
Weiqi Wang, and Yilan Jin, and Zhiai Xu, and Xiao Liu, and Sadia Z Bajwa, and Waheed S Khan, and Haijun Yu
January 2018, Theranostics,
Copied contents to your clipboard!